Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/107441
DC FieldValueLanguage
dc.contributor.authorBrandão, Pedro-
dc.contributor.authorLópez, Óscar-
dc.contributor.authorLeitzbach, Luisa-
dc.contributor.authorStark, Holger-
dc.contributor.authorFernández-Bolaños, José G.-
dc.contributor.authorBurke, Anthony J.-
dc.contributor.authorPineiro, Marta-
dc.date.accessioned2023-07-12T09:27:45Z-
dc.date.available2023-07-12T09:27:45Z-
dc.date.issued2021-11-11-
dc.identifier.issn1948-5875pt
dc.identifier.urihttps://hdl.handle.net/10316/107441-
dc.description.abstractMolecular hybridization is a valuable approach in drug discovery. Combining it with multicomponent reactions is highly desirable, since structurally diverse libraries can be attained efficiently in an eco-friendly manner. In this work, isatin is used as the key building block for the Ugi 4-center 3-component reaction synthesis of oxindole-lactam hybrids, under catalyst-free conditions. The resulting oxindole-β-lactam and oxindole-γ-lactam hybrids were evaluated for their potential to inhibit relevant central nervous system targets, namely cholinesterases and monoamine oxidases. Druglikeness evaluation was also performed, and compounds 4eca and 5dab exhibited great potential as selective butyrylcholinesterase inhibitors, at the low micromolar range, with an interesting predictive pharmacokinetic profile. Our findings herein reported suggest oxindole-lactam hybrids as new potential agents for the treatment of Alzheimer's disease.pt
dc.language.isoengpt
dc.publisherACS American Chemical Societypt
dc.relationP. Brandão acknowledges FCT for the PhD grant PD/BD/ 128490/2017-CATSUS FCT-PhD Program. Coimbra Chemistry Centre (CQC) is supported by the Portuguese Agency for Scientific Research, “Fundação para a Ciência e a Tecnologia” (FCT) through project UIDB/00313/2020 and UIDP/00313/ 2020, cofunded by COMPETE2020-UE. We also acknowledge the UC-NMR facility for obtaining the NMR data (www. nmrccc.uc.pt). This work was also financed by the FEDER Funds through the Operational Competitiveness Factors ProgramCOMPETEand by National Funds through FCTFoundation for Science and Technologywithin the scope of the project UIDB/50006/2020. Ó. López would also like to thank the Dirección General de Investigación of Spain (CTQ2016-78703-P), Junta de Andalucía (FQM134), and FEDER (501100008530) for financial support. Partial support from the EU COST Actions CA15135 (to HS and AJB), CA18133 (to HS), and CA18240 (to HS) is also acknowledged.pt
dc.rightsembargoedAccesspt
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt
dc.titleUgi Reaction Synthesis of Oxindole-Lactam Hybrids as Selective Butyrylcholinesterase Inhibitorspt
dc.typearticle-
degois.publication.firstPage1718pt
degois.publication.lastPage1725pt
degois.publication.issue11pt
degois.publication.titleACS Medicinal Chemistry Letterspt
dc.peerreviewedyespt
dc.identifier.doi10.1021/acsmedchemlett.1c00344pt
degois.publication.volume12pt
dc.date.embargo2022-11-11*
uc.date.periodoEmbargo365pt
item.grantfulltextopen-
item.cerifentitytypePublications-
item.languageiso639-1en-
item.openairetypearticle-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextCom Texto completo-
crisitem.author.researchunitCQC - Coimbra Chemistry Centre-
crisitem.author.researchunitCQC - Coimbra Chemistry Centre-
crisitem.author.parentresearchunitFaculty of Sciences and Technology-
crisitem.author.parentresearchunitFaculty of Sciences and Technology-
crisitem.author.orcid0000-0002-1455-7470-
crisitem.author.orcid0000-0002-7460-3758-
Appears in Collections:I&D CQC - Artigos em Revistas Internacionais
Files in This Item:
File Description SizeFormat
Brandao2021ACSMedChemLett.pdf2.89 MBAdobe PDFView/Open
Show simple item record

SCOPUSTM   
Citations

12
checked on May 6, 2024

WEB OF SCIENCETM
Citations

13
checked on May 2, 2024

Page view(s)

39
checked on May 7, 2024

Download(s)

18
checked on May 7, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons